Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: hellmann ns. AIDS. 2002 Oct 18;16(15):F33-40. doi: 10.1097/00002030-200210180-00001. AIDS. 2002. PMID: 12370520 Clinical Trial.
Practical applications of viral fitness in clinical practice.
Bates M, Wrin T, Huang W, Petropoulos C, Hellmann N. Bates M, et al. Among authors: hellmann n. Curr Opin Infect Dis. 2003 Feb;16(1):11-8. doi: 10.1097/00001432-200302000-00003. Curr Opin Infect Dis. 2003. PMID: 12821824 Review.
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz.
Bosch RJ, Downey GF, Katzenstein DA, Hellmann N, Bacheler L, Albrecht MA; ACTG 364 Study Team. Bosch RJ, et al. Among authors: hellmann n. AIDS. 2003 Nov 7;17(16):2395-6. doi: 10.1097/00002030-200311070-00016. AIDS. 2003. PMID: 14571193 No abstract available.
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.
Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ. Brown AJ, et al. Among authors: hellmann ns. J Virol. 2000 Nov;74(22):10269-73. doi: 10.1128/jvi.74.22.10269-10273.2000. J Virol. 2000. PMID: 11044070 Free PMC article.
125 results